Ackman's Pershing Square ends 2015 with 20.5 pct drop
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Valeant Pharma (VRX) Sees Sharp Upside
January 5, 2016 10:53 AM ESTValeant Pharma (NYSE: VRX) is seeing upside today. Chatter is that either Bill Ackman is buying back the stock that he recently sold for tax purposes and/or CEO Mike Pearson's condition is improving. Shares are up 4.8%.
... More